Novartis today announced results from an updated analysis of the pivotal Phase III NATALEE trial of Kisqali® (ribociclib) that underscore the extended efficacy beyond the duration of treatment in ...
In today’s fast-paced world, maintaining optimal health can often feel like a daunting task. Many individuals struggle with managing their blood sugar levels, which can lead to various health ...